Journal article
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H Elliott, Fiona Wightman, Ajantha Solomon, Khader Ghneim, Jeffrey Ahlers, Mark J Cameron, Miranda Z Smith, Tim Spelman, James McMahon, Pushparaj Velayudham, Gregor Brown, Janine Roney, Jo Watson, Miles H Prince, Jennifer F Hoy, Nicolas Chomont, Remi Fromentin, Francesco A Procopio, Joumana Zeidan, Sarah Palmer Show all
PLOS PATHOGENS | PUBLIC LIBRARY SCIENCE | Published : 2014
Grants
Awarded by Australian National Health and Medical Research Council
Awarded by Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (DARE: Delaney AIDS Research Enterprise)
Awarded by American Foundation for AIDS Research
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding Acknowledgements
The study was supported in part by a research grant from the Investigator Initiated Studies Program of Merck Sharp & Dohme Corp. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp. This work was supported in part by the Australian National Health and Medical Research Council (APP1042654, Dora Lush Postgraduate Scholarship APP607230, CJ Martin Overseas Biomedical Fellowship GNT0490988, Early Career Fellowship APP1037839) and the Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (DARE: Delaney AIDS Research Enterprise; U19AI096109). RF is supported by the American Foundation for AIDS Research (108264). SRL is a NHMRC Practitioner Fellow and RWJ is an NHMRC Principal Research Fellow. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.